Selective serotonin reuptake inhibitors for premenstrual syndrome and premenstrual dysphoric disorder.

SSRIs probably reduce premenstrual symptoms in women with PMS and PMDD and are probably more effective when taken continuously compared to luteal phase administration. SSRI treatment probably increases the risk of adverse events, with the most common being nausea, asthenia and somnolence.